iShares Genomics Immunology and Healthcare ETF IDNA

Medalist Rating as of | See iShares Investment Hub

Morningstar’s Analysis IDNA

Will IDNA outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

iShares Genomics Immnlgy & Hlthcr ETF holds a quantitatively derived Bronze Morningstar Medalist Rating. The rating reflects that it has scored better than the norm on factors Morningstar research associates with future outperformance relative to category peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings IDNA

  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 48.3
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Moderna Inc

11.20 35M
Healthcare

Twist Bioscience Corp

7.70 24M
Healthcare

Iovance Biotherapeutics Inc

4.98 15M
Healthcare

Genmab AS

3.98 12M
Healthcare

Revolution Medicines Inc Ordinary Shares

3.79 12M
Healthcare

Bayer AG

3.60 11M
Healthcare

Merck & Co Inc

3.32 10M
Healthcare

Takeda Pharmaceutical Co Ltd

3.30 10M
Healthcare

Regeneron Pharmaceuticals Inc

3.29 10M
Healthcare

Incyte Corp

3.27 10M
Healthcare

Sponsor Center